XOMA Royalty (XOMA) Interest Coverage Ratio Growth (1y) (2012 - 2026)
XOMA Royalty (XOMA) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
67.94% |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
-108.36% |
| Date | Value |
|---|
| Mar 31, 2026 |
-108.36% |
| Dec 31, 2025 |
61.03% |
| Sep 30, 2025 |
91.00% |
| Jun 30, 2025 |
148.01% |
| Mar 31, 2025 |
186.70% |
| Jun 30, 2021 |
-187.19% |
| Mar 31, 2021 |
-114.63% |
| Dec 31, 2020 |
1,066.24% |
| Sep 30, 2020 |
-203.73% |
| Jun 30, 2020 |
44.31% |
| Mar 31, 2020 |
-329.60% |
| Dec 31, 2019 |
26.80% |
| Sep 30, 2019 |
123.52% |
| Jun 30, 2019 |
33.72% |
| Mar 31, 2019 |
114.93% |
| Dec 31, 2018 |
39.36% |
| Sep 30, 2018 |
-117.90% |
| Jun 30, 2018 |
-480.67% |
| Mar 31, 2018 |
-68.52% |
| Dec 31, 2017 |
15.43% |
